2010 Annual Symposium Agenda Program Photos Reports(English) Reports(Chinese)
Abstracts & Speaker Biosketches
Professor Joseph Francisco, President, American Chemical Society
He has published over 400 peer-reviewed publications in the fields of atmospheric chemistry, chemical kinetics, quantum chemistry, laser photochemistry and spectroscopy. He was appointed by the Secretary of the Navy to be member of the Naval Research Advisory Committee for the Department of Navy (1994-1996). He has served as a member of the Editorial Advisory Boards of Spectrochimica Acta (Part A); Advances in Environmental Research; Journal of Molecular Structure Theochem; and the Journal of Physical Chemistry. He is a co-author of the textbook Chemical Kinetics and Dynamics, published by Prentice-Hall.
Professor Francisco has received numerous national and international honors for his academic accomplishments. He was recently awarded an Alexander von Humboldt U.S. Senior Scientist Award by the German government, as well as being appointed a Senior Visiting Fellow at the Institute of Advanced Studies at the University of Bologna, Italy. He has been appointed to and served on committees for the National Research Council, National Science Foundation, American Chemical Society, and the National Aeronautics and Space Administration.
Dr. Ji Zhang, Vice President & Head of Clinical Sciences and Operations, sanofi-aventis
In this talk, I will share the key missions of a clinical development and operations organization, describe core values various groups bring, and through this example, discuss with you the competitive advantages of a WW organization with core competencies from different regions of the world. I believe Chinese Americans continue to play critical roles in this transformation, and should take opportunities to lead.
Before assuming the above role, Ji was head of International Clinical Operations; and prior to joining sanofi-aventis, he was Senior Director, Clinical Biostatistics, Merck Research Laboratories in Rahway, NJ.
Ji Zhang holds a B.S. and M.S. in Mathematics, Probability and Statistics from Peking University, China; and a Ph.D. in Statistics from North Carolina State University. He was author or co-author of over 40 peer reviewed scientific papers. He is very active in professional associations in various leadership and service roles, and is an elected Fellow of the American Statistical Association.
Ji is also active in his community volunteering for several worthy causes. He served on the Huaxia Chinese School (Edison) Board of Trustees for 3 years and was chair for one year. He is currently serving on the Board of Directors, PAMS Foundation of North Carolina State University, and successfully co-led the effort to establish a fund for a named (RA Fisher) professorship at NC State University.
Dr. Robert V. Slone, R&D Director, Formulation Science – Core R&D, The Dow Chemical Company
Abstract This presentation will focus on the technical and cultural aspects of building and maintaining a high performance R&D group in China. Moving a team from the time of hiring, through training and retention to ultimately joining a global research community on equal footing with other major regional R&D facilities is a key challenge many technology-related corporations face. This presentation will share some of the successes and pitfalls along that path. Some examples that illustrate regional innovations and capabilities will be presented as well.
Bio Rob Slone is currently the R&D Director for Formulation Science in the Core R&D group of the Dow Chemical Company. His group is responsible for new formulation design and includes the High Throughput Research groups of Dow Chemical. Rob has recently returned to Spring House, Pennsylvania from a two year assignment in Shanghai, China during which he led the hiring, training and development of the Adhesives and Functional Polymers R&D team in Shanghai.
Rob is the author of the “Acrylic Ester Polymers” and “Methacrylic Ester Polymers” chapters of the Kirk-Othmer Encyclopedia of Chemical Technology and 2010 Encyclopedia of Polymer Science and Technology. He holds 18 patents.
Rob joined the Rohm and Haas Company (now Dow Chemical) in 1997 after receiving his Ph.D. in Inorganic Chemistry from Northwestern University and received his BS Chemistry degree from the University of North Carolina at Chapel Hill in 1993.
Dr. Scott Grossman, Vice President & Scientific Director, BioCon Bristol-Myers Squibb Research Center
From 1987 to 1998, Dr. Grossman worked in the Safety Assessment Department of Merck Research Laboratories rising to the position of Director, Biochemical Toxicology and Investigative Toxicology.
Seeking a ‘new career’ in Drug Discovery, he joined DuPont Pharmaceuticals in 1998 as Director, Research Support. Following the DuPont acquisition by Bristol-Myers Squibb Co. in 2001, Dr. Grossman became Executive Director of Metabolism and Pharmacokinetics at BMS.
In 2003 Dr. Grossman was made Vice President, Pharmaceutical Candidate Optimization at Bristol Myers Squibb Co. This group comprises disciplines of Analytical and Bioanalytical Sciences, Biotransformation, Pharmacokinetics, Pharmaceutics, and Toxicology in Discovery and/or Development. This group’s mission is to minimize drug attrition through optimization, improved selection, and problem-solving during the development of drug candidates.
Dr. Grossman is currently VP, Scientific Director, for the Biocon Bristol-Myers Squibb Research Center in Bangalore India.
Ingrid Cole, Vice President of Technical Solutions, Henkel Industrial Adhesive Business
Abstract Sustainability has been a key initiative in the adhesive’s industry. Retailers such as Wal-Mart have been a key driver in sustainability. They have set the standards for the products and packaging materials that can be sold in their stores by developing scorecards and rating their vendors to determine preferred supplier status. The adhesive is generally one component in the construction of a final product. Therefore the industry must be focused on developing products that can adhere to new more sustainable materials as well as initiatives around improving the sustainability of the adhesive. This has led to several innovations that address both issues. Sustainability is broad but can be broken down into five focal areas which include initiatives in energy and climate, water and waste water, materials and waste, health and safety and social progress. In this presentation examples of innovative solutions will be discussed from the five focal areas.
Bio Ingrid Cole graduated from the University of Florida with a BS in Chemistry and a MS in Materials Science and Engineering. She started her career in 1992 at National Starch and Chemical as a product development chemist developing adhesives for packaging and converting applications. She has held a number of product development management roles supporting packaging, converting, tapes, labels, hygienics and construction markets. She holds several patents in the area of low application temperature adhesives.
She is currently VP of Technical Solutions at Henkel in their Industrial Adhesives Business. This group’s primary objective is to deliver value through products, service and process improvements at our customers as well as deliver efficiency and quality improvement in their manufacturing plants.
Dr. Tim Barckholtz, Director, Petroleum Science Lab, Corporate Strategic Research, ExxonMobil Research and Engineering Co.
Abstract Each year, ExxonMobil prepares a projection of global energy consumption based on expected growth in population, economic development, technology progress, and so on. In this talk, I will present the results of this year's Energy Outlook, and analyze the results in a variety of ways. Energy consumption is expected to grow at an annual rate of about 1.2%, driven by growth in population (0.9%/year) and economic development (2.7%/year). Energy consumption is expected to be stagnant in the developed countries, although the mix of energy types will be changing. However, energy consumption will be dramatic in the developing world, driven by rapid economic growth in China, India and other countries. While renewable sources of energy will grow at significant rates, in 2030 they will still represent a fairly low percentage of the total primary energy sources. The talk will include discussion of advanced vehicle technology, economic impacts of CO2 management, and supply/demand factors.
Bio Tim holds a Ph. D. in chemistry from The Ohio State University. Following a post-doctoral fellowship at the National Institute of Standards and Technology / University of Colorado, Tim joined ExxonMobil Research and Engineering in 2001, initially working in advanced combustion technology. In 2005, he was part of a team that commercialized a process to reduce NOx emissions from fluidized catalytic crackers, the largest point sources of NOx in refineries with FCC units. In 2006, he relocated to the company's Fairfax, VA office where he held positions in EMRE's planning division. While in Fairfax, he transferred to ExxonMobil Refining & Supply, where he coordinated the crude purchasing and supply chain logistics for the company's refineries in Texas and Louisiana that have a combined processing capability of 1.6 million barrels per day. In 2009, he returned to Clinton, NJ and assumed his current position as manager of the company's R&D efforts in the front end of the pipeline for refining and lubricants.
Dr. Xiaochun Luo, Group Vice President & Chief Scientific Officer, Global Research & Development, Avon “Leadership and Leadership Quality --- A Personal Perspective”
Abstract In the corporate world, Asian Americans are generally viewed as a highly technical group, while we were not viewed equally highly as leaders. The talk will provide my personal point of view on what leadership means and what are some of the behaviors that portrait one as a leader. I will also discuss some behaviors that are barriers preventing us from being effective leaders.
Bio Dr. Xiaochun Luo is recently appointed as Group Vice President and Chief Scientific Officer leading Avon’s Global Research and Development efforts responsible for development and support of the company’s worldwide product lines.
Xiaochun joined Avon in December of 1999 as Director for Global Hair Care. She was promoted to Executive Director in May of 2001 and to Vice President of New Technology and New Product Innovation in December of 2002. In May of 2010 she was promoted to her current position to lead the Global R&D organization in its drive for innovation and development of breakthrough technologies in beauty products.
Prior to joining Avon, Xiaochun spent close to ten years in Global R&D of Procter & Gamble Company. She spent three years in Japan establishing and leading a New Technology organization for P&G’s Asian-Pacific region. Xiaochun holds a Ph.D. in Biochemistry from Purdue University and has authored numerous scientific papers, book chapter and patents in biological research fields.
Charles Ye, CEO of Acesys Pharmaceutical Inc.
DIRECTIONS: Busch Campus Center
All contents Copyright © 2004-2019 All rights reserved.
Web Design by Genie Studio